Type 2 Diabetes Mellitus
📧 Sign up to get email alerts when something new happens for Type 2 Diabetes Mellitus.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2014-04-02Clinical Trial Update: Effect of Vitamin D Supplementation on the Metabolic Control and Body Composition of Type 2 Diabetes Subjects in Ajman (UAE) [NA]
A completed clinical trial evaluating the effect of vitamin D supplementation on metabolic control and body composition in adults with type …
-
FDA approval · 2014-04-01FDA Approved: INSULIN LISPRO — Supplemental Application (Eli Lilly and Company)
FDA approved a supplemental application for insulin lispro submitted by Eli Lilly and Company.
-
CLINICAL_TRIALS trial_result · 2014-04-01Clinical Trial Update: Comparative Effectiveness of Bariatric Surgery Versus Medical Management to Induce Diabetes Remission in Diabetic Patients With BMI 30-35
This completed trial compares bariatric surgery to medical management for inducing diabetes remission in adults with type 2 diabetes and BMI…
-
CLINICAL_TRIALS trial_result · 2014-04-01Clinical Trial Update: Dyslipidemia and Risk of Cardiovascular Disease in Diabetic Men and Women
A completed clinical trial evaluating the relationship between dyslipidemia and cardiovascular disease risk in men and women with diabetes.
-
CLINICAL_TRIALS trial_result · 2014-03-31Clinical Trial Update: A Study to Evaluate the Effect of Ranolazine on Postprandial Glucagon in Subjects With Type 2 Diabetes. [Phase 1]
A Phase 1 clinical trial update reporting the completion of a study evaluating ranolazine's effect on postprandial glucagon in adults with T…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2014-03-31Clinical Trial Update: Whey Protein on Posprandial Glucose, Insulin GLP-1, GIP and DPP4 in Type 2 Diabetes [NA]
Completed clinical trial evaluating whey protein's effects on postprandial glucose, insulin GLP-1, GIP, and DPP-4 in Type 2 Diabetes.
-
CLINICAL_TRIALS trial_result · 2014-03-27Clinical Trial Update: Obstructive Sleep Apnea (OSA), Sleepiness, and Activity in Diabetes Management [Phase 3]
Phase 3 trial update evaluating obstructive sleep apnea in adults with type 2 diabetes; results have been posted following completion.
-
CLINICAL_TRIALS trial_result · 2014-03-26Clinical Trial Update: Metformin Add-on Regimen Comparison Study in Japanese Participants With Type 2 Diabetes Mellitus (MK-0431A-136) [Phase 3]
Phase 3 clinical trial assessing metformin add-on regimens in Japanese participants with type 2 diabetes mellitus; study completed with resu…
-
CLINICAL_TRIALS research · 2014-03-26Clinical Trial Update: Genetic Variation in the Transporters and Hypoglycemic Agents
This clinical trial update examines how genetic variation in drug transporters affects responses to hypoglycemic medications in people with …
-
CLINICAL_TRIALS research · 2014-03-24Clinical Trial Update: Evaluation of an Intervention Based on Cell Phones [NA]
This document reports the completion of a clinical trial in Mexico evaluating a cell phone–based intervention for Type 2 Diabetes Mellitus. …
-
CLINICAL_TRIALS trial_result · 2014-03-24Clinical Trial Update: Evaluation of Low Blood Sugar Events in Participants With Diabetes (MK-0431-401)
Merck-sponsored trial MK-0431-401 evaluated the incidence of hypoglycemic events in participants with Type 2 Diabetes Mellitus; results were…
-
FDA approval · 2014-03-24FDA Approved: GLYBURIDE — Supplemental Application (Teva Pharmaceuticals USA, Inc.)
FDA approved a supplemental application for glyburide by Teva Pharmaceuticals USA, Inc. under ANDA074686.
-
CLINICAL_TRIALS trial_result · 2014-03-24Clinical Trial Update: (Cost-)Effectiveness of SLIMMER Diabetes Prevention Intervention [NA]
An update on the cost-effectiveness evaluation of the SLIMMER diabetes prevention intervention. The trial focuses on Type 2 diabetes mellitu…
-
CLINICAL_TRIALS trial_result · 2014-03-21Clinical Trial Update: Alimentation and Diabetes in Lanzarote - ADILAN: a Pilot Trial [NA]
This clinical trial update reports the completed pilot study ADILAN assessing alimentation strategies for adults with Type 2 diabetes mellit…
-
CLINICAL_TRIALS trial_result · 2014-03-21Clinical Trial Update: Effect of Physical Exercise on Endothelial Function in Patients With Type 2 Diabetes Mellitus [NA]
This clinical trial update reports the completion of a study evaluating the effect of physical exercise on endothelial function in patients …
-
CLINICAL_TRIALS trial_result · 2014-03-20Clinical Trial Update: Safety and Efficacy Study of Insulin Lispro Versus Insulin Aspart in Participants With Type 2 Diabetes on Insulin Pump Therapy [Phase 3]
A Phase 3 study comparing insulin lispro versus insulin aspart in people with type 2 diabetes on insulin pump therapy completed, with result…
-
CLINICAL_TRIALS trial_result · 2014-03-20Clinical Trial Update: Study of Dapagliflozin in Combination With Metformin XR to Initiate the Treatment of Type 2 Diabetes [Phase 3]
Phase 3 trial evaluating initiating Type 2 diabetes treatment with a combination of dapagliflozin and metformin XR; results were posted in 2…
-
FDA approval · 2014-03-20FDA Approved: METFORMIN HYDROCHLORIDE — Supplemental Application (Westminster Pharmaceuticals, LLC)
The FDA approved Westminster Pharmaceuticals, LLC's supplemental application for metformin hydrochloride.
-
CLINICAL_TRIALS withdrawal · 2014-03-19Clinical Trial Update: Impact of Web-based Care Management for Poorly Controlled Type 2 Diabetes Mellitus: a Randomized, Controlled Trial [NA]
A randomized controlled trial sponsored by Kaiser Permanente evaluating web-based care management for poorly controlled Type 2 Diabetes Mell…
-
FDA approval · 2014-03-18FDA Approved: INSULIN LISPRO — Supplemental Application (Eli Lilly and Company)
FDA approved a supplemental application for insulin lispro from Eli Lilly and Company.
-
FDA approval · 2014-03-18FDA Approved: JANUMET — Supplemental Application (Merck Sharp & Dohme LLC)
FDA approved a supplemental application for JANUMET (sitagliptin and metformin hydrochloride) from Merck Sharp & Dohme LLC. The document not…
-
FDA approval · 2014-03-18FDA Approved: HUMULIN 70/30 — Supplemental Application (Eli Lilly and Company)
The FDA approved a supplemental application for Humulin 70/30 (insulin human) submitted by Eli Lilly and Company.
-
FDA approval · 2014-03-18FDA Approved: HUMALOG MIX50/50 KWIKPEN — Supplemental Application (Eli Lilly and Company)
The FDA approved a supplemental application for HUMALOG MIX50/50 KWIKPEN (insulin lispro) from Eli Lilly and Company; this action updates th…
-
CLINICAL_TRIALS trial_result · 2014-03-18Clinical Trial Update: A Study to Assess the Safety, Tolerability and Glucose-Lowering Efficacy of MK-0893 in Participants With Type 2 Diabetes Mellitus (MK-0893-005) [Phase 2]
Phase 2 trial update for MK-0893 assessing safety, tolerability, and glucose-lowering efficacy in type 2 diabetes mellitus; study completed …
-
CLINICAL_TRIALS trial_result · 2014-03-18Clinical Trial Update: Efficacy, Safety and Satisfaction of the New Pen Needle 33 Gauge x 4 mm. [NA]
A completed clinical trial by Consorzio Mario Negri Sud evaluating the efficacy, safety, and patient satisfaction of a new 33-gauge × 4-mm i…